Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The European Respiratory Journal|August 10, 2000
Nedocromil sodium in the treatment of exercise-induced asthma: a meta-analysisC Spooner, B H Rowe, L D Saunders
Australian Journal of Public Health|March 1, 1992
Prevalences and perceptions of licit and illicit drugs among New South Wales secondary school students, 1989N Donnelly, S Quine, B Oldenburg, et al.
Australian Journal of Public Health|March 1, 1992
Changes in reported drug prevalence among New South Wales secondary school students, 1983 to 1989N Donnelly, B Oldenburg, S Quine, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Early emergency department treatment of acute asthma with systemic corticosteroidsB H Rowe, C Spooner, F M Ducharme, et al.
The Cochrane Database of Systematic Reviews|May 2, 2001
Early emergency department treatment of acute asthma with systemic corticosteroidsB H Rowe, C Spooner, F M Ducharme, et al.
The British Journal of Nutrition|January 1, 1987
The use of monensin or formaldehyde to control the digestion of the nitrogenous constituents of perennial ryegrass (Lolium perenne cv. Melle) and white clover (Trifolium repens cv. Blanca) in the rumen of cattleD E Beever, H R Losada, D L Gale, et al.
The British Journal of Nutrition|November 1, 1985
The digestion of fresh perennial ryegrass (Lolium perenne L. cv. Melle) and white clover (Trifolium repens L. cv. Blanca) by growing cattle fed indoorsD E Beever, D J Thomson, M J Ulyatt, et al.
The British Journal of Nutrition|September 1, 1988
The effect of date of cut and barley substitution on gain and on the efficiency of utilization of grass silage by growing cattle. 2. Nutrient supply and energy partitionD E Beever, S B Cammell, C Thomas, et al.
The British Journal of Nutrition|May 1, 1986
The efficiency of energy utilization in growing cattle consuming fresh perennial ryegrass (Lolium perenne cv. Melle) or white clover (Trifolium repens cv. Blanca)S B Cammell, D J Thomson, D E Beever, et al.
The Journal of Infectious Diseases|January 1, 1994
Clinical safety, tolerability, and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-alphaL D Saravolatz, J C Wherry, C Spooner, et al.
Pageof 4